Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsDiscover high-efficiency, cell-internalizing human antibodies from our vast premade libraries, engineered for ADC development and intracellular payload delivery.
Identify antibodies with inherent internalization properties, optimized for efficient payload delivery and therapeutic efficacy.
Our function-first screening strategy enriches for clones that are actively transported into the cell, not just surface binders.
Interrogate a wide range of epitopes to find the precise binding site that triggers optimal receptor-mediated endocytosis.
Start with human frameworks engineered to minimize immunogenicity and downstream CMC challenges.
From Vast Diversity to Intracellular Delivery. Powering Your Next-Generation ADCs and Biologics.
Finding antibodies that not only bind but also internalize efficiently is a critical bottleneck in developing Antibody-Drug Conjugates (ADCs) and other targeted therapies. Standard screening often yields high-affinity binders that remain on the cell surface, failing to deliver their therapeutic payload. Creative Biolabs' service combines the vast diversity of our premade human antibody libraries with a purpose-built functional screening platform. We deliver downstream-ready, internalizing candidates with the speed and precision your program demands.
Screening Platform: A Strategy for Intracellular Success
Our advanced phage and yeast display platforms are specifically tuned to isolate rare internalizing antibodies from libraries of immense diversity. Through multi-parameter panning strategies, competitive selection against decoys, and sophisticated cell-based functional assays, we systematically eliminate non-internalizing binders and prioritize candidates with superior trafficking properties. We directly overcome common hurdles like low internalization rates, epitope redundancy, and off-target binding, delivering candidates that are not just binders, but potent delivery vehicles poised for ADC development and in vivo validation.
Target assessment; antigen format optimization (soluble protein vs. cell surface); internalization pathway hypothesis; competitor/decoy planning.
Up to 5 rounds of panning with increasing stringency; cell-based panning on target-expressing lines to ensure native conformation recognition.
Primary screening of hundreds of unique clones via high-throughput ELISA or flow cytometry to confirm target binding on cells.
High-content imaging or fluorescence-based assays to directly measure antibody internalization rates and efficiency.
NGS-driven clonotype clustering; in silico liability screening for PTMs, deamidation, and aggregation-prone motifs.
Expression of top leads as full-length IgG; biophysical characterization (stability, aggregation) and preliminary conjugation suitability checks.
Our libraries are the foundation of discovery. Engineered for diversity, stability, and developability, they provide a world-class starting point for any therapeutic antibody program. Jump directly to our library options to find the perfect starting point for your project.
| Antibody Library ID | Display Technology | Library Format | Library Size |
|
HuScL-6 ☆Highly Recommended |
pIII-fusion, Phagemid Phage Display | Naïve scFv | 2.1×1011 |
| HuScL-3S | pIII-fusion, Phagemid Phage Display | Semi-synthetic scFv | >1.0×1011 |
| HuFabL-4 | pIII-fusion, Phagemid Phage Display | Naïve Fab | 1.9×1010 |
| HuFabssL-1 | pIII-fusion, Phagemid Phage Display | Naïve & synthetic Fab | 1.8×1010 |
| Precision Discovery of Internalizing Antibodies for Complex Primary Cells | ||||||
| Strategic Goal | Identify antibodies that selectively bind and internalize into specific primary human cells while avoiding cross-reactivity with diverse background cell populations. | |||||
| Project Framework | Starting Materials | Target Cell (Primary Human T1) vs. Control Cell (Negative Mixture N1). | ||||
| Integrated Workflow |
We utilized a sophisticated Cell-Based Negative/Positive Biopanning workflow to ensure maximum specificity.
|
|||||
| Key Results |
|
|||||
Find additional antibody discovery services tailored to your specific needs.
We design antibodies to give you therapeutics.
Powered by industry-leading library technology, our platform is built to deliver more targeted antibodies faster than ever before. We've assembled the finest antibody and antibody-technology experts and coupled them with world-class biologists to get you results you can trust.
Synergy for Internalization.
Our 1e11 diversity libraries are paired with purpose-built, cell-based functional assays, ensuring the binders we find are the antibody you need.
Binding and internalization is just the start.
We help you avoid late-stage dead ends by giving you an early look at conjugation suitability and biophysical stability for those all-important ADC-ready candidates.
Our screening strategy doesn't just chase high affinity.
We take a function-first approach, selecting for the desired internalization from the get-go to avoid wasting time on high-affinity antibodies that just can't do their job.
Speeding discovery. We know you need to act fast.
That's why our entire screening workflow is lean, integrated and ready to deliver validated, IgG-formatted internalizes ready to conjugate, all in record time.
We're not just antibody experts.
Our team has deep functional biology and intracellular trafficking expertise across the entire antibody-technology space, so we understand the nuanced details of your target's biology and design screening strategies that make sense for your target's mechanism of action.
You can count on Creative Biolabs.
We share end-to-end data including NGS-driven sequence analysis and deliver clean, transparent reports with clear next steps that make it easy to confidently decide what's best for your project and team. Handoffs to your team are a breeze.
Ready to find the cell-internalizing antibodies you need to move your target forward? Our team is here to help and would love to design a discovery campaign with you that will meet your target and therapeutic goals. At Creative Biolabs, we don't just deliver data; we deliver candidates and a clear plan for the next steps.
In order to give you the most accurate and informative response, please include the following information:
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
